Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis
Xiao Zheng, Yawei Zhao, Yong Jia, et al.
Biomaterials (2021) Vol. 271, pp. 120716-120716
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy
Shuwen Fu, Guanting Li, Wenli Zang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 92-106
Open Access | Times Cited: 159
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 144
A metal ions-mediated natural small molecules carrier-free injectable hydrogel achieving laser-mediated photo-Fenton-like anticancer therapy by synergy apoptosis/cuproptosis/anti-inflammation
Wenmin Pi, Linying Wu, Jihui Lu, et al.
Bioactive Materials (2023) Vol. 29, pp. 98-115
Open Access | Times Cited: 53
Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform
Qiuyan Guo, Shengmei Wang, Rubing Xu, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10608-10637
Open Access | Times Cited: 19
Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer
Qiaoqi Chen, Liang Zhang, Lin Li, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 63
Emerging small molecule-engineered hybrid nanomedicines for cancer therapy
Yao Chen, Tongyao Zhao, Meiyu Bai, et al.
Chemical Engineering Journal (2022) Vol. 435, pp. 135160-135160
Closed Access | Times Cited: 49
Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
Yi Zhun Zhu, Na Xie, Yilu Chai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 47
Berberine as a potential agent for breast cancer therapy
Xiao-Dan Zhong, Lijuan Chen, Xin-Yang Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 46
Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
Haonan Dong, Lu Zhang, Suling Liu
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3421-3434
Open Access | Times Cited: 44
HMGB1 in the interplay between autophagy and apoptosis in cancer
Ruochan Chen, Zou Ju, Xiao Yan Zhong, et al.
Cancer Letters (2023) Vol. 581, pp. 216494-216494
Closed Access | Times Cited: 27
At the crossroad of nanotechnology and cancer cell membrane coating: Expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting
Huachun Pan, Shumin Yang, Lun Gao, et al.
Coordination Chemistry Reviews (2024) Vol. 506, pp. 215712-215712
Closed Access | Times Cited: 16
Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling
Shengqi Wang, Jing Li, Shicui Hong, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 11
Hepatic‐Accumulated Obeticholic Acid and Atorvastatin Self‐Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic‐Associated Fatty Liver Disease
Huanfen Lu, Zhenglan Ban, Kai Xiao, et al.
Advanced Science (2024) Vol. 11, Iss. 10
Open Access | Times Cited: 10
Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives
Lanwen Gao, Fansu Meng, Zhenjiang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117327-117327
Open Access | Times Cited: 9
Killing three birds with one stone: Multi-stage metabolic regulation mediated by clinically usable berberine liposome to overcome photodynamic immunotherapy resistance
Chunjuan Zheng, Wenjuan Luo, Yu Liu, et al.
Chemical Engineering Journal (2022) Vol. 454, pp. 140164-140164
Closed Access | Times Cited: 29
Emerging trends and research foci of berberine on tumor from 2002 to 2021: A bibliometric article of the literature from WoSCC
Runzhu Yuan, Yao Tan, Ping‐Hui Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Special Issue: Nanotherapeutics in Women's Health Emerging Nanotechnologies for Triple‐Negative Breast Cancer Treatment
Sofia Torres Quintas, Ana Manuela Canha Borges, Maria José Oliveira, et al.
Small (2023)
Open Access | Times Cited: 22
Challenges and opportunities for improving the druggability of natural product: Why need drug delivery system?
Peng Tang, Tianze Shen, Hairong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114955-114955
Open Access | Times Cited: 19
Review of Carrier-Free Self-Assembly of Anticancer Nanodrugs
Haixia Ji, Wenzhe Wang, Ou Qiao, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 5, pp. 4564-4587
Closed Access | Times Cited: 7
Integration of STING activation and COX-2 inhibition via steric-hindrance effect tuned nanoreactors for cancer chemoimmunotherapy
Pengfei Zhang, Di Zhong, Yongbo Yu, et al.
Biomaterials (2024) Vol. 311, pp. 122695-122695
Closed Access | Times Cited: 7
Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
Sajad Fakhri, Seyed Zachariah Moradi, Akram Yarmohammadi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer
Xiaoyan Yang, Jinguo Zhang, Qiao-Mei Zhou, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Construction of Nanocarriers Based on Endogenous Cell Membrane and Their Application in Nanomedicine
Yingshu Guo, Wenxin Li, Shiwei Liu, et al.
Chinese Journal of Chemistry (2022) Vol. 40, Iss. 13, pp. 1623-1640
Closed Access | Times Cited: 23
Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis
Tianyu Li, Tolulope Akinade, Jie Zhou, et al.
Advanced Science (2022) Vol. 9, Iss. 33
Open Access | Times Cited: 23
pH-/Redox-Responsive Nanodroplet Combined with Ultrasound-Targeted Microbubble Destruction for the Targeted Treatment of Drug-Resistant Triple Negative Breast Cancer
Shan Xiao, Lu Guo, Ai Chen, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 7, pp. 8958-8973
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top